Jacob Cozean Holter

Mr. Jacob Cozean Holter

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
JHJacob Cozean Holter
Jacob Cozean Holter
CCChia-Wen Chang
Chia-Wen Chang
AAAlex Avendano
Alex Avendano
AGAyush A. Garg
Ayush A. Garg
AVAjeet K. Verma
Ajeet K. Verma
JSJonathan W. Song
Jonathan W. Song
Cancer-associated fibroblasts (CAFs) play an active role in remodeling the local tumor stroma to support tumor initiation, growth, invasion, metastasis, and therapeutic resistance. The CAF-secreted chemokine, CXCL12, has been directly implicated in the tumorigenic progression of carcinomas, including breast cancer. Using a 3-D in vitro microfluidic-based microtissue model, we demonstrate that stromal CXCL12 secreted by CAFs has a potent effect on increasing the vascular permeability of local blood microvessel analogues through paracrine signaling. Moreover, genetic deletion of fibroblast-specific CXCL12 significantly reduced vessel permeability compared to CXCL12 secreting CAFs within the recapitulated tumor microenvironment (TME). We suspected that fibroblast-mediated extracellular matrix (ECM) remodeling and contraction indirectly accounted for this change in vessel permeability. To this end, we investigated the autocrine effects of CXCL12 on fibroblast contractility and determined that antagonistic blocking of CXCL12 did not have a substantial effect on ECM contraction. Our findings indicate that fibroblast-secreted CXCL12 has a significant role in promoting a leakier endothelium hospitable to angiogenesis and tumor cell intravasation; however, autocrine CXCL12 is not the primary upstream trigger of CAF contractility.

7 October 2024 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
SAShashwat Agarwal
Shashwat Agarwal
MCMarcos Cortes-Medina
Marcos Cortes-Medina
JHJacob Cozean Holter
Jacob Cozean Holter
AAAlex Avendano
Alex Avendano
JTJoseph W. Tinapple
Joseph W. Tinapple
JSJonathan W. Song
Jonathan W. Song
Blood and lymphatic vessels in the body are central to molecular and cellular transport, tissue repair, and pathophysiology. Several approaches have been employed for engineering microfabricated blood and lymphatic vessels in vitro, yet traditionally these approaches require specialized equipment, facilities, and research training beyond the capabilities of many biomedical laboratories. Here we present xurography as an inexpensive, accessible, and versatile rapid prototyping technique for engineering cylindrical and lumenized microvessels. Using a benchtop xurographer, or a cutting plotter, we fabricated modular multi-layer poly(dimethylsiloxane) (PDMS)-based microphysiological systems (MPS) that house endothelial-lined microvessels approximately 260 μm in diameter embedded within a user-defined 3-D extracellular matrix (ECM). We validated the vascularized MPS (or vessel-on-a-chip) by quantifying changes in blood vessel permeability due to the pro-angiogenic chemokine CXCL12. Moreover, we demonstrated the reconfigurable versatility of this approach by engineering a total of four distinct vessel-ECM arrangements, which were obtained by only minor adjustments to a few steps of the fabrication process. Several of these arrangements, such as ones that incorporate close-ended vessel structures and spatially distinct ECM compartments along the same microvessel, have not been widely achieved with other microfabrication strategies. Therefore, we anticipate that our low-cost and easy-to-implement fabrication approach will facilitate broader adoption of MPS with customizable vascular architectures and ECM components while reducing the turnaround time required for iterative designs.

19 March 2025 in Micromachines
Verified
Journal Article
Open access
PDF file
SAShashwat Agarwal
Shashwat Agarwal
JHJacob Cozean Holter
Jacob Cozean Holter
TJTravis Jones
Travis Jones
BFBrendan T Fuller
Brendan T Fuller
.T. Joseph W. Tinapple
. Joseph W. Tinapple
JSJonathan W. Song
Jonathan W. Song
Continuous perfusion is necessary to sustain microphysiological systems and other microfluidic cell cultures. However, most of the established microfluidic perfusion systems, such as syringe pumps, peristaltic pumps, and rocker plates, have several operational challenges and may be cost-prohibitive, especially for laboratories with no microsystems engineering expertise. Here, we address the need for a cost-efficient, easy-to-implement, and reliable microfluidic perfusion system. Our solution is a modular pumpless perfusion assembly (PPA), which is constructed from commercially available, interchangeable, and aseptically packaged syringes and syringe filters. The total cost for the components of each assembled PPA is USD 1–2. The PPA retains the simplicity of gravity-based pumpless flow systems but incorporates high resistance filters that enable slow and sustained flow for extended periods of time (hours to days). The perfusion characteristics of the PPA were determined by theoretical calculations of the total hydraulic resistance of the assembly and experimental characterization of specific filter resistances. We demonstrated that the PPA enabled reliable long-term culture of engineered endothelialized 3-D microvessels for several weeks. Taken together, our novel PPA solution is simply constructed from extremely low-cost and commercially available laboratory supplies and facilitates robust cell culture and compatibility with current microfluidic setups.

2 December 2022
Verified
Book Chapter
Closed access
PDF file
CCChia-Wen Chang
Chia-Wen Chang
JHJacob Cozean Holter
Jacob Cozean Holter
JSJonathan W. Song
Jonathan W. Song
Advancing our understanding of the metastasis-promoting properties of the tumor microenvironment (TME) requires mechanistic studies of tumor biology and functional responses at the cellular, sub-cellular, and molecular levels. Microfluidic models offer several advantages over traditional in vitro and in vivo platforms including the incorporation of fluid pressure and biomolecular concentration gradients, optical compatibility, and the specification of cellular and matrix compositions for more relevant 3D physiological recapitulation. For instance, microfluidics enables the application of highly controllable physicochemical properties such as gradients of oxygen (O2) tension and oncogenic signaling molecules, fluid mechanical stimuli, and biophysical tissue matrix stiffness and solid stress. Microphysiological systems can be used to uncover the role of these tractable factors and the potent migratory cues they impart onto malignant cells, which promote and maintain cancer invasion. Consequently, there is significant interest in leveraging microfluidic models to develop novel therapies that target the TME as it relates to invasive and metastatic progression. Here, we examine the application of microfluidic systems, which have emerged as versatile in vitro disease models of the TME that enable unprecedented control of microenvironmental factors for systematic experimentation and predictive drug testing.

7 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SAShashwat Agarwal
Shashwat Agarwal
JHJacob Cozean Holter
Jacob Cozean Holter
TJTravis Jones
Travis Jones
BFBrendan T Fuller
Brendan T Fuller
.T. Joseph W. Tinapple
. Joseph W. Tinapple
JSJonathan W. Song
Jonathan W. Song
Continuous perfusion is necessary to sustain microphysiological systems and other microfluidic cell cultures. However, most of the established microfluidic perfusion systems, such as syringe pumps, peristaltic pumps, and rocker plates, have several operational challenges and may be cost-prohibitive, especially for laboratories with no microsystems engineering expertise. Here, we address the need for a cost-efficient, easy-to-implement, and reliable microfluidic perfusion system. Our solution is a modular pumpless perfusion assembly (PPA), which is constructed from commercially available, interchangeable, and aseptically packaged syringes and syringe filters. The total cost for the components of each assembled PPA is $1-2 USD. The PPA retains the simplicity of gravity-based pumpless flow systems but incorporates high resistance filters that enable slow and sustained flow for extended periods of time (hours to days). The perfusion characteristics of the PPA were determined by theoretical calculations of the total hydraulic resistance of the assembly and experimental characterization of specific filter resistances. We demonstrated that the PPA enabled reliable long-term culture of engineered endothelialized 3-D microvessels for several weeks. Taken together, our novel PPA solution is simply constructed from extremely low cost and commercially available laboratory supplies and facilitates robust cell culture and compatibility with current microfluidic setups.

5 April 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
JHJacob Cozean Holter
Jacob Cozean Holter
SAShashwat Agarwal
Shashwat Agarwal
JTJoseph W. Tinapple
Joseph W. Tinapple
JBJoseph M. Barlage
Joseph M. Barlage
TJTravis Jones
Travis Jones
JSJonathan W. Song
Jonathan W. Song
The transport function of lymphatic vessels is altered during tissue injury, inflammation, and cancer. Defects in lymphatic function are associated with changes to the biophysical microenvironment, including pressure and flow. However, the ability of fluid forces to orchestrate the remodeling of blind‐ended lymphatic vessels and lymphangiogenesis is not well understood. Here, a novel microphysiological system (MPS) is developed that recapitulates the blind‐ended microanatomy and fluid absorption properties of capillary lymphatics. This MPS implements a continuum of pressure‐driven interstitial, transmural, and luminal flow to mimic fluid forces naturally present within the lymphatic microenvironment. Interstitial flow (IF) and vascular endothelial growth factor C (VEGF‐C) cooperated during lymphangiogenesis. Notably, sprouting was most prominent at the blind‐ended region of lymphatic vessels where transmural flow was highest in the MPS. Moreover, IF guided invading sprouts into the surrounding extracellular matrix (ECM) antiparallel to streamlines within a nonuniform three‐dimensional (3‐D) flow field. Strikingly, flow‐induced elongation and axial alignment of intraluminal cells propagated to vessel‐level phenotypic differences, such as vasoconstriction and helical patterning. The structural remodeling of these lymphatic vessels was concurrent with lymphangiogenesis. These results reveal how extravascular and intraluminal endothelial cells integrate signals from native fluid forces to coordinate the expansion and remodeling of capillary lymphatics.